招股书显示，国恩科技是一家专注于化工新材料及明胶、胶原蛋白上下游产品的中国供应商。根据弗若 斯特沙利文的资料，于2024年，按销售收入计，国恩科技是中国第二大的有机高分子改性材料及有机高 分子复合材料企业，市场份额为2.5%。此外，于2024年，国恩科技按产能计是中国最大的聚苯乙烯企 业。 国恩科技(02768)尾盘拉升逾13%，高见54.45港元创上市新高，截至发稿，涨10.33%，报51.9港元，成 交额9540.06万港元。 值得注意的是，2月4日，深交所公告称，因国恩科技在港交所上市不适用价格稳定期机制，且相应A股 上市满10个交易日，根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发 生调整并自2026年2月4日起生效，调入国恩科技。 ...

值得注意的是，2月4日，深交所公告称，因国恩科技在港交所上市不适用价格稳定期机制，且相应A股 上市满10个交易日，根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发 生调整并自2026年2月4日起生效，调入国恩科技。 智通财经APP获悉，国恩科技(02768)尾盘拉升逾13%，高见54.45港元创上市新高，截至发稿，涨 10.33%，报51.9港元，成交额9540.06万港元。 招股书显示，国恩科技是一家专注于化工新材料及明胶、胶原蛋白上下游产品的中国供应商。根据弗若 斯特沙利文的资料，于2024年，按销售收入计，国恩科技是中国第二大的有机高分子改性材料及有机高 分子复合材料企业，市场份额为2.5%。此外，于2024年，国恩科技按产能计是中国最大的聚苯乙烯企 业。 ...

格隆汇2月13日丨国恩科技(02768.HK)涨8.21%，报50.9000港元，股价创历史新高，总市值153.34亿港 元。 ...

1、港股通最新日占比增持榜（前20名） | 公司名称 | 占比值变动 | 最新持股比例 | | --- | --- | --- | | 钧达股份(02865) | +5.09% | 58.82% | | 狮腾控股(02562) | +1.26% | 49.45% | | 復旦张江(01349) | +1.15% | 41.95% | | 喜相逢集团(02473) | +1.12% | 29.42% | | 中国中免(01880) | +0.97% | 34.55% | | 匯聚科技(01729) | +0.82% | 7.97% | | 天岳先进(02631) | +0.77% | 27.69% | | 长飞光纤光缆(06869) | +0.61% | 57.83% | | 美图公司(01357) | +0.55% | 30.53% | | 兆易创新(03986) | +0.54% | 1.35% | | 晶泰控股(02228) | +0.52% | 41.63% | | 安井食品(02648) | +0.52% | 43.67% | | 英诺赛科(02577) | +0.46% | 13.85% | | 云 ...

Core Viewpoint - The report highlights the AH premium rates of various companies, indicating significant discrepancies between their H-shares and A-shares, with some companies showing extremely high premiums while others exhibit negative premiums [1]. Group 1: Top AH Premium Rates - Northeast Electric (00042) has the highest AH premium rate at 831.03%, with H-share priced at 0.290 HKD and A-share at 2.25 CNY [1]. - Sinopec Oilfield Service (01033) follows with a premium rate of 296.70%, H-share at 0.910 HKD and A-share at 3.01 CNY [1]. - Beijing Jingcheng Machinery Electric (00187) ranks third with a premium of 285.05%, H-share at 4.280 HKD and A-share at 13.76 CNY [1]. Group 2: Lowest AH Premium Rates - Contemporary Amperex Technology (03750) has the lowest AH premium rate at -13.27%, with H-share priced at 511.000 HKD and A-share at 370 CNY [1]. - China Merchants Bank (03968) shows a premium of -4.06%, H-share at 49.300 HKD and A-share at 39.49 CNY [1]. - WuXi AppTec (02359) has a premium of -2.14%, with H-share at 120.800 HKD and A-share at 98.7 CNY [1]. Group 3: Top Deviation Values - Jinju Group (02009) has the highest deviation value at 24.42%, with a premium of 212.05% [1]. - Beijing Jingcheng Machinery Electric (00187) has a deviation value of 21.92%, with a premium of 285.05% [1]. - Longpan Technology (02465) ranks third with a deviation value of 19.68%, and a premium of 101.01% [1]. Group 4: Lowest Deviation Values - JunDa Co., Ltd. (02865) has the lowest deviation value at -70.56%, with a premium of 176.15% [2]. - Changfei Optical Fiber (06869) follows with a deviation of -45.38%, and a premium of 105.94% [2]. - Chenming Paper (01812) has a deviation of -26.81%, with a premium of 190.80% [2].

Group 1 - The core viewpoint of the article highlights that Guoen Technology (02768) has transferred shares from Morgan Stanley Hong Kong Securities to Huatai Hong Kong, with a market value of HKD 68.6328 million, accounting for 5.53% of the total shares [1] - Guoen Technology officially listed on the Hong Kong Stock Exchange on February 4, and was included in the Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving the chemical and health industries through research, production, and sales of industrial and commercial products [1] Group 2 - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, with a market share of 2.5% projected for 2024 [1]

Group 1 - The core viewpoint of the article highlights that Guo'en Technology (02768) has transferred shares from Morgan Stanley Hong Kong Securities to Huatai Hong Kong, with a market value of HKD 68.6328 million, representing 5.53% of the total shares [1] - Guo'en Technology officially listed on the Hong Kong Stock Exchange on February 4 and was included in the Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] Group 2 - According to Frost & Sullivan, Guo'en Technology is the second-largest organic polymer modified materials and organic polymer composite materials enterprise in China by sales revenue, with a market share of 2.5% projected for 2024 [1]

Core Insights - The report by CITIC Financial Holdings Wealth Committee Asset Management Studio highlights the stable development of China's asset management industry since the implementation of new regulations, with various financial institutions participating and competing effectively [1][3] Industry Overview - As of the end of 2025, the total scale of China's asset management industry is projected to reach 184.53 trillion yuan, representing a growth of approximately 13.1% compared to the previous year [1][3] - The industry encompasses multiple segments, including bank wealth management, public funds, insurance asset management, trusts, securities firms' asset management, and private equity funds [1][3] Segment Breakdown - The breakdown of the asset management industry by segment as of the end of 2025 is as follows: - Bank wealth management: 33.29 trillion yuan - Public funds: 37.71 trillion yuan - Private equity funds: 22.15 trillion yuan - Pension funds managed by fund companies: 6.85 trillion yuan - Private asset management by securities and futures institutions: 12.30 trillion yuan - Insurance fund utilization balance: 37.46 trillion yuan - Trust assets managed by trust companies: 32.43 trillion yuan [1][3] Product Trends - By the end of 2025, the number of existing bank wealth management products is expected to reach 46,300, reflecting a growth of 14.89% since the beginning of the year [2][4] - Fixed-income products dominate the investment types, with a significant share of the total scale; the structure of open-ended and closed-end products is relatively balanced [2][4] - Although the number of newly issued products by wealth management companies slightly decreased in the fourth quarter of 2025, the diversity of product types has increased, with joint-stock bank wealth management subsidiaries remaining the main issuers [2][4]

Summary of Key Points Core Viewpoint - The A-share IPO market is active with three companies approved for listing, while the Hong Kong IPO market continues to thrive, particularly in the innovative drug and high-end manufacturing sectors, with several key players making significant moves [2][6]. Group 1: A-share IPO Approvals - Three companies received approval for IPOs this week: Guangdong Huahui Intelligent Equipment Co., Ltd., Anhui Xinfeng New Energy Technology Co., Ltd., and Shandong Chunguang Technology Group Co., Ltd. [2][3][4]. - Huahui Intelligent focuses on high-end intelligent equipment and has seen rapid revenue growth, projecting over 4.2 billion yuan in revenue for 2024 and over 620 million yuan in net profit [3]. - Xinfeng Technology specializes in thermal management components for electric vehicles, with projected revenues of 6 billion yuan in 2024 and 13.81 billion yuan in 2025 [4][5]. - Chunguang Group leads in the production of soft magnetic ferrite powder, with revenues of 10.15 billion yuan in 2022 and a planned fundraising of 7.51 billion yuan for its IPO [5]. Group 2: Hong Kong IPO Market Activity - The Hong Kong IPO market welcomed five new listings, including four companies and one on the Sci-Tech Innovation Board, covering diverse sectors such as chemical new materials and cardiovascular medical devices [6][7]. - Guoen Technology debuted on the Hong Kong Stock Exchange, raising approximately 1 billion HKD, with plans for expansion in Thailand and domestic production [6]. - Beixin Life, the first medical device company listed on the Sci-Tech Innovation Board, saw its stock price surge by 183.33% on its first day, focusing on cardiovascular intervention devices [7]. - Leading companies in the PCB equipment sector, such as Dazhu CNC, raised significant funds for expansion into Southeast Asia, while Zhuozheng Medical and Muyuan Foods had mixed performances post-listing [8]. Group 3: Upcoming IPOs and Market Trends - The Hong Kong IPO market continues to be driven by hard technology, with companies like Danuo Pharmaceutical and Xian Dao Intelligent preparing for their listings, focusing on innovative drugs and lithium battery equipment [9][10]. - Danuo Pharmaceutical is set to raise funds for global clinical advancements, with its core product showing promising clinical data [9]. - Xian Dao Intelligent aims to raise 41.66 billion HKD, with a significant projected profit increase of 424% by 2025, expanding its services beyond lithium battery equipment [10]. - Wolong Nuclear Materials is also preparing for an IPO, focusing on new materials and global capacity expansion, with a fundraising target of up to 27.34 billion HKD [11].

Group 1 - The core viewpoint of the article highlights that Guoen Technology (02768) experienced a decline of over 5% on its second day of trading, closing at HKD 37.94 with a transaction volume of HKD 117 million [1] - Guoen Technology officially listed on the Hong Kong Stock Exchange on February 4 and was included in the Hong Kong Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] Group 2 - According to the prospectus, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, holding a market share of 2.5% as of 2024 [1]